Intensive treatment for the progression of joint damage in rheumatoid arthritis patients with low disease activity or remission

被引：0

作者：

Mochizuki, Takeshi ^{[1
,4
]}

Koenuma, Naoko ^{[2
]}

Yano, Koichiro ^{[2
]}

Ikari, Katsunori ^{[2
,3
]}

Hiroshima, Ryo ^{[1
]}

Okazaki, Ken ^{[2
]}

机构：

[1] Kamagaya Gen Hosp, Dept Orthopaed Surg, Chiba, Japan

[2] Tokyo Womens Med Univ, Dept Orthopaed Surg, Tokyo, Japan

[3] Tokyo Womens Med Univ, Div Multidisciplinary Management Rheumat Dis, Tokyo, Japan

[4] Kamagaya Gen Hosp, Dept Orthopaed Surg, 929-6 Hatsutomi, Kamagaya, Chiba 2730121, Japan

来源：

MODERN RHEUMATOLOGY | 2024年 / 34卷 / 02期

关键词：

Intensive treatment; joint damage; low disease activity; remission; rheumatoid arthritis; AMERICAN-COLLEGE; METHOTREXATE; THERAPY; DRUG;

D O I：

10.1093/mr/road041

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Objectives To investigate the effects of intensive treatment on joint damage in patients with rheumatoid arthritis (RA) showing progression of joint damage and low disease activity or remission. Methods Eighty-nine patients who had change in the van der Heijde modified total Sharp score (TSS) of >0.5 points at baseline when compared with the score 1 year ago were enrolled and categorized into two groups to receive intensive (intensive group) or current (current group) treatment. The intensive and current groups were compared for change (Delta) from baseline to 1 year of erosion score, joint space narrowing score, and TSS. Results The Delta TSS values at 1 year in the intensive and current groups were 0.67 +/- 1.09 and 1.79 +/- 1.70, respectively (P < 0.001). In the intensive and current groups, the Delta TSS <= 0.5 at 1 year were 66.7% and 32.4%, respectively (P = 0.010). Conclusions The intensive treatment was more effective at suppressing joint damage than the current treatment. The progression of joint damage is an important target to consider for intensive treatment.

引用

页码：329 / 333

页数：5

共 20 条

[11] Progression of radiologic damage in patients with rheumatoid arthritis in clinical remission [J].

Molenaar, ETH ;

Voskuyl, AE ;

Dinant, HJ ;

Bezemer, PD ;

Boers, M ;

Dijkmans, BAC .

ARTHRITIS AND RHEUMATISM, 2004, 50 (01) :36-42

[12] Therapies for Active Rheumatoid Arthritis after Methotrexate Failure [J].

O'Dell, James R. ;

Mikuls, Ted R. ;

Taylor, Thomas H. ;

Ahluwalia, Vandana ;

Brophy, Mary ;

Warren, Stuart R. ;

Lew, Robert A. ;

Cannella, Amy C. ;

Kunkel, Gary ;

Phibbs, Ciaran S. ;

Anis, Aslam H. ;

Leatherman, Sarah ;

Keystone, Edward .

NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (04) :307-318

[13] EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update [J].

Smolen, Josef S. ;

Landewe, Robert B. M. ;

Bijlsma, Johannes W. J. ;

Burmester, Gerd R. ;

Dougados, Maxime ;

Kerschbaumer, Andreas ;

McInnes, Iain B. ;

Sepriano, Alexandre ;

van Vollenhoven, Ronald F. ;

de Wit, Maarten ;

Aletaha, Daniel ;

Aringer, Martin ;

Askling, John ;

Balsa, Alejandro ;

Boers, Maarten ;

den Broeder, Alfons A. ;

Buch, Maya H. ;

Buttgereit, Frank ;

Caporali, Roberto ;

Cardiel, Mario Humberto ;

De Cock, Diederik ;

Codreanu, Catalin ;

Cutolo, Maurizio ;

Edwards, Christopher John ;

van Eijk-Hustings, Yvonne ;

Emery, Paul ;

Finckh, Axel ;

Gossec, Laure ;

Gottenberg, Jacques-Eric ;

Hetland, Merete Lund ;

Huizinga, Tom W. J. ;

Koloumas, Marios ;

Li, Zhanguo ;

Mariette, Xavier ;

Mueller-Ladner, Ulf ;

Mysler, Eduardo F. ;

da Silva, Jose A. P. ;

Poor, Gyula ;

Pope, Janet E. ;

Rubbert-Roth, Andrea ;

Ruyssen-Witrand, Adeline ;

Saag, Kenneth G. ;

Strangfeld, Anja ;

Takeuchi, Tsutomu ;

Voshaar, Marieke ;

Westhovens, Rene ;

van der Heijde, Desiree .

ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 (06) :685-699

[14] Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force [J].

Smolen, Josef S. ;

Breedveld, Ferdinand C. ;

Burmester, Gerd R. ;

Bykerk, Vivian ;

Dougados, Maxime ;

Emery, Paul ;

Kvien, Tore K. ;

Navarro-Compan, M. Victoria ;

Oliver, Susan ;

Schoels, Monika ;

Scholte-Voshaar, Marieke ;

Stamm, Tanja ;

Stoffer, Michaela ;

Takeuchi, Tsutomu ;

Aletaha, Daniel ;

Louis Andreu, Jose ;

Aringer, Martin ;

Bergman, Martin ;

Betteridge, Neil ;

Bijlsma, Hans ;

Burkhardt, Harald ;

Cardiel, Mario ;

Combe, Bernard ;

Durez, Patrick ;

Fonseca, Joao Eurico ;

Gibofsky, Alan ;

Gomez-Reino, Juan J. ;

Graninger, Winfried ;

Hannonen, Pekka ;

Haraoui, Boulos ;

Kouloumas, Marios ;

Landewe, Robert ;

Martin-Mola, Emilio ;

Nash, Peter ;

Ostergaard, Mikkel ;

Ostor, Andrew ;

Richards, Pam ;

Sokka-Isler, Tuulikki ;

Thorne, Carter ;

Tzioufas, Athanasios G. ;

van Vollenhoven, Ronald ;

de Wit, Martinus ;

van der Heijde, Desiree .

ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 (01) :3-15

[15] RETRACTED: Safety and effectiveness of high-dose methotrexate (over 8 mg/week) in 2838 Japanese patients with rheumatoid arthritis: a postmarketing surveillance report (Retracted Article) [J].

Suzuki, Yasuo ;

Sugiyama, Naonobu ;

Fukuma, Yuri ;

Sugiyama, Noriko ;

Kokubo, Takeshi .

MODERN RHEUMATOLOGY, 2020, 30 (01) :24-35

[16] Long-term sustained remission in a cohort study of patients with rheumatoid arthritis: choice of remission criteria [J].

Svensson, Bjorn ;

Andersson, Maria L. E. ;

Bala, Sidona-Valentina ;

Forslind, Kristina ;

Hafstrom, Ingiald .

BMJ OPEN, 2013, 3 (09)

[17] High anti-cyclic citrullinated peptide levels and an algorithm of four variables predict radiographic progression in patients with rheumatoid arthritis:: results from a 10-year longitudinal study [J].

Syversen, S. W. ;

Gaarder, P. I. ;

Goll, G. L. ;

Odegard, S. ;

Haavardsholm, E. A. ;

Mowinckel, P. ;

van der Heijde, D. ;

Landewe, R. ;

Kvien, T. K. .

ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (02) :212-217

[18] Predictors of new bone erosion in rheumatoid arthritis patients receiving conventional synthetic disease-modifying antirheumatic drugs: Analysis of data from the DRIVE and DESIRABLE studies [J].

Takeuchi, Tsutomu ;

Soen, Satoshi ;

Ishiguro, Naoki ;

Yamanaka, Hisashi ;

Tanaka, Sakae ;

Kobayashi, Makiko ;

Okubo, Naoki ;

Nitta, Takaya ;

Tanaka, Yoshiya .

MODERN RHEUMATOLOGY, 2021, 31 (01) :34-41

[19] Effect of interleukin-6 receptor inhibitor, tocilizumab, in preventing joint destruction in patients with rheumatoid arthritis showing inadequate response to TNF inhibitors [J].

Tanaka, Yoshiya ;

Takeuchi, Tsutomu ;

Amano, Koichi ;

Saito, Kazuyoshi ;

Hanami, Kentaro ;

Nawata, Masao ;

Fukuyo, Shunsuke ;

Kameda, Hideto ;

Kaneko, Yuko ;

Kurasawa, Takahiko ;

Nagasawa, Hayato ;

Hoshi, Daisuke ;

Sato, Eri ;

Yamanaka, Hisashi .

MODERN RHEUMATOLOGY, 2014, 24 (03) :399-404

[20] The relationship between disease activity and radiologic progression in patients with rheumatoid arthritis -: A longitudinal analysis [J].

Welsing, PMJ ;

Landewé, RBM ;

van Riel, PLCM ;

Boers, M ;

van Gestel, AM ;

van der Linden, S ;

Swinkels, HL ;

van der Heijde, DMFM .

ARTHRITIS AND RHEUMATISM, 2004, 50 (07) :2082-2093

← 1 2 →